Health Catalyst HCAT Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Health Catalyst in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: Health Catalyst’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Health Catalyst's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Health Catalyst's cash & equivalents?
- Health Catalyst (HCAT) reported cash & equivalents of $59.86M in Q1 2026.
- How has Health Catalyst's cash & equivalents changed year-over-year?
- Health Catalyst's cash & equivalents decreased by 82.5% year-over-year, from $341.97M to $59.86M.
- What is the long-term trend for Health Catalyst's cash & equivalents?
- Over 5 years (2020 to 2025), Health Catalyst's cash & equivalents has grown at a -11.2% compound annual growth rate (CAGR), from $91.95M to $50.81M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.